BERLIN — Patients with restless legs syndrome (RLS) for whom conventional therapies are contraindicated may benefit from a treatment usually reserved for patients with advanced Parkinson's disease and ...
August 4, 2011 — A new study is the first long-term prospective trial of dopamine agonist therapy in restless legs syndrome (RLS). The study, funded by UCB BioSciences and Schwarz Pharma, ...
Restless Legs Syndrome is a highly prevalent sensorimotor disorder characterized by an irresistible urge to move the limbs, ...
A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest ...
Restless legs syndrome: a new practice guideline Evidence shows strong support for prescribing pramipexole, rotigotine, cabergoline, or gabapentin enacarbil to treat adults with restless legs syndrome ...
Credit: Getty Images The American Academy of Sleep Medicine published guidance regarding the treatment of restless leg syndrome and periodic limb movement disorder. The American Academy of Sleep ...
Restless Legs Syndrome (RLS), or Willis-Ekbom disease (WED) is one of the most common chronic sensorimotor neurological conditions encountered by clinicians. It occurs in 5% to 10% of the adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results